Skip to content
Home » Resources » Awareness of Genomic Testing in Breast Cancer: A Call to Action Across Europe

Awareness of Genomic Testing in Breast Cancer: A Call to Action Across Europe

    myCancer myConcern – Awareness of Genomic testing in Breast Cancer

    Awareness of Genomic Testing in Breast Cancer: A Call to Action Across Europe

    Publication format: White Paper
    Year: 2023
    Topic: Advocacy, Equity / Access
    Language: English
    View this resource

    This White Paper, produced by Cancer Patients Europe under the myC initiative, presents findings from a 2022 pan-European patient survey across five countries examining awareness of genomic testing in early-stage breast cancer. Results reveal critical gaps: 78% of eligible patients were never informed genomic testing was available to them. The document issues a formal Call to Action directed at policymakers, healthcare professionals, and patient organisations to improve access, reimbursement, education, and shared decision-making around genomic and precision medicine tools in breast cancer care.